Hoppa till huvudinnehåll

Egna kontroller vid diabetes mellitus

Medicinska yrkesverksamma

Professionella referensartiklar är utformade för att användas av vårdpersonal. De är skrivna av brittiska läkare och baserade på forskningsbevis, brittiska och europeiska riktlinjer. Du kan hitta Blodglukostest (blodsocker) och HbA1c artikel mer användbar, eller en av våra andra hälsoartiklar.

The role of glucose monitoring

Self-monitoring of blood glucose is considered an effective tool for the management of diabetes, especially for those who require insulin treatment.1

Self-monitoring gives regular feedback for the patient; however, decisions on both the method and frequency of testing need to be made on an individual basis. Monitoring is only useful if it is used to inform decisions (eg, adjusting tablets or insulin dosage).

Diabetes empowerment improves diabetes self-care behaviours (including diet, physical activity, blood glucose monitoring and foot care).2

Studies have shown that when patients perform self-monitoring, support through appropriate educational initiatives is critical to ensure that patients understand the rationale for self-monitoring of blood glucose.3 See also the separate Diabetes Education and Self-management Programmes artikel.

Methods of monitoring glucose

Various methods of glucose monitoring are available, including HbA1c measurement, blood glucose monitoring and urine testing. NB: urine testing is not recommended but may be useful for some patients with diet- or tablet-controlled type 2 diabetes mellitus - for example, as a warning sign of high glucose levels when unwell.

Blood glucose monitoring4

Blood glucose monitoring using a meter gives a direct measure of the glucose concentration at the time of the test and can detect hypoglycaemia as well as hyperglycaemia.

Patients should be properly trained in the use of blood glucose monitoring systems and to take appropriate action on the results obtained. Inadequate understanding of the normal fluctuations in blood glucose can lead to confusion and inappropriate action.

Although glucose meters are not prescribable at NHS expense, manufacturers often provide them free to patients, on the basis of income made from the testing strips, which are prescribable at NHS expense and each type of testing strip is specific to each monitor.

Continuous glucose monitoring (CGM)

Subcutaneous CGM machines show real-time glucose on the monitor and have alarms to indicate hypoglycaemia and hyperglycaemia.5

Typ 2-diabetes

National Institute for Health and Care Excellence (NICE) recommendations for patients with type 2 diabetes6

Do not routinely offer self-monitoring of blood glucose levels for adults with type 2 diabetes unless:

  • The person is on insulin; or

  • There is evidence of hypoglycaemic episodes; or

  • The person is on oral medication that may increase their risk of hypoglycaemia while driving or operating machinery; or

  • The person is pregnant or is planning to become pregnant.

Consider short-term self-monitoring of blood glucose levels in adults with type 2 diabetes (and review treatment as necessary):

  • When starting treatment with oral or intravenous corticosteroids; or

  • To confirm suspected hypoglycaemia.

If adults with type 2 diabetes are self-monitoring their blood glucose levels, carry out a structured assessment at least annually. The assessment should include:

  • The person's self-monitoring skills.

  • The quality and frequency of testing.

  • Checking that the person knows how to interpret the blood glucose results and what action to take.

  • The impact on the person's quality of life.

  • The continued benefit to the person.

  • The equipment used.

People with type 2 diabetes who are not using insulin

Although self-monitoring of blood glucose has been found to be effective for patients with type 1 diabetes and for patients with type 2 diabetes using insulin, evidence suggests that self-monitoring of blood glucose is of limited clinical effectiveness in improving glycaemic control in people with type 2 diabetes on oral agents or diet alone.7

A Cochrane review found that the overall effect of self-monitoring of blood glucose on glycaemic control in patients with type 2 diabetes who are not using insulin is small up to six months after initiation and subsides after 12 months.

There was no evidence that self-monitoring of blood glucose affected patient satisfaction, general well-being or general health-related quality of life.8

Exklusiva uppdateringar för vårdpersonal

Håll dig informerad med de senaste kliniska uppdateringarna, professionella insikter och evidensbaserad vägledning. Patient Pro-nyhetsbrevet sammanställer viktigt innehåll för vårdpersonal—levererat direkt till din inkorg.

Vänligen ange en giltig e-postadress

Genom att prenumerera accepterar du våra Sekretesspolicy. Du kan avsluta prenumerationen när som helst. Vi säljer aldrig dina uppgifter.

Vidare läsning och referenser

  1. Russell-Minda E, Jutai J, Speechley M, et al; Health technologies for monitoring and managing diabetes: a systematic review. J Diabetes Sci Technol. 2009 Nov 1;3(6):1460-71.
  2. Hernandez-Tejada MA, Campbell JA, Walker RJ, et al; Diabetes empowerment, medication adherence and self-care behaviors in adults with type 2 diabetes. Diabetes Technol Ther. 2012 Jul;14(7):630-4. doi: 10.1089/dia.2011.0287. Epub 2012 Apr 23.
  3. Blevins T; Value and utility of self-monitoring of blood glucose in non-insulin-treated patients with type 2 diabetes mellitus. Postgrad Med. 2013 May;125(3):191-204. doi: 10.3810/pgm.2013.05.2668.
  4. Brittiska nationella läkemedelsformuläret (BNF); NICE Evidenstjänster (endast tillgång i Storbritannien)
  5. Kim HS, Shin JA, Chang JS, et al; Continuous glucose monitoring: current clinical use. Diabetes Metab Res Rev. 2012 Dec;28 Suppl 2:73-8. doi: 10.1002/dmrr.2346.
  6. Type 2 diabetes in adults: management; NICE Guidance (December 2015 - last updated June 2022)
  7. Clar C, Barnard K, Cummins E, et al; Self-monitoring of blood glucose in type 2 diabetes: systematic review. Health Technol Assess. 2010 Mar;14(12):1-140. doi: 10.3310/hta14120.
  8. Malanda UL, Welschen LM, Riphagen II, et al; Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin. Cochrane Database Syst Rev. 2012 Jan 18;1:CD005060. doi: 10.1002/14651858.CD005060.pub3.

Om författarenVisa fullständig biografi

Författarbild

Dr Colin Tidy, MRCGP

Allmänläkare, Medicinsk Författare

MBBS, MRCGP, MRCP (Paediatrics), DCH

Dr Colin Tidy är en NHS-läkare, baserad i Oxfordshire.

Om recensentenVisa fullständig biografi

Författarbild

Dr Krishna Vakharia, MRCGP

Medicinsk chef för hälsa, Optum UK

MBChB, MRCGP(2013), BMedSci (hons), DFSRH, DRCOG, PGDipDerm (Distn)

Dr Krishna Vakharia är en NHS-läkare. Hon är också en regelbunden examinator för den postgraduate Diplom i Praktisk Dermatologi vid Cardiff University samt Chief Medical Officer för hälsa på Optum UK.

Artikelhistorik

Informationen på denna sida är skriven och granskad av kvalificerade kliniker.

influensaberättigandekontroll

Fråga, dela, anslut.

Bläddra i diskussioner, ställ frågor och dela erfarenheter inom hundratals hälsorelaterade ämnen.

symptomkontroll

Känner du dig sjuk?

Bedöm dina symtom online gratis